bioRxivCancer Biology
Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
M. Pun, D. Pratt, P. R. Nano, P. K. Joshi, L. Jiang, B. Englinger, A. Rao, M. Cieslik, A. M. Chinnaiyan, K. Aldape, S. Pfister, M. Filbin, A. Bhaduri, S. Venneti
Abstract
AbstractGlobally decreased histone 3, lysine 27 tri-methylation (H3K27me3) is a hallmark of H3K27-altered diffuse midline gliomas (DMGs) and group-A posterior fossa ependymomas (PFAs). H3K27-altered DMGs are largely characterized by lysine-to- methionine mutations in histone 3 at position 27 (H3K27M). Most PFAs overexpress EZH inhibitory protein (EZHIP), which possesses a region of similarity to the mutant H3K27M. Both H3K27M and EZHIP inhibit function of the polycomb repressive complex 2 (PRC2) responsible for H3K27me3 deposition. These tumors often arise in neighboring regions of the brainstem and posterior fossa. In rare cases PFAs harbor H3K27M mutations, and DMGs overexpress EZHIP. These findings together raise the possibility that certain cell populations in the developing hindbrain/posterior fossa are especially sensitive to modulation of H3K27me3 states. We identified shared molecular features by comparing genomic, bulk transcriptomic, chromatin-based profiles, and single-cell RNA-sequencing (scRNA-seq) data from the two tumor classes. Our approach demonstrated that 1q gain, a key biomarker in PFAs, is prognostic in H3.1K27M, but not H3.3K27M gliomas. Conversely, Activin A Receptor Type 1 (ACVR1), which is associated with mutations in H3.1K27M gliomas, is overexpressed in a subset of PFAs with poor outcome. Despite diffuse H3K27me3 reduction, previous work shows that both tumors maintain genomic H3K27me3 deposition at select sites. We demonstrate heterogeneity in shared patterns of residual H3K27me3 for both tumors that largely segregated with inferred anatomic tumor origins and progenitor populations of tumor cells. In contrast, analysis of genes linked to H3K27 acetylation (H3K27ac)-marked enhancers showed higher expression in astrocytic-like tumor cells. Finally, common H3K27me3-marked genes mapped closely to expression patterns in the human developing hindbrain. Overall, our data demonstrate developmentally relevant molecular similarities between PFAs and H3K27M DMGs and support the overall hypothesis that deregulated mechanisms of hindbrain development are central to the biology of both tumors.
- organism: human
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
S. U. Jain, T. J. Do, … P. W. Lewis·Nature CommunicationsPeer-reviewed·May 13, 2019
- H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3 in Diffuse Midline Glioma
Suraj Bhattarai, Faruck Lukmanul Hakkim, … James P. Robinson·Epigenetics & ChromatinPeer-reviewed·Apr 26, 2025
- Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars
Kasey Skinner, Tomoyuki Koga, … Frank B. Furnari·bioRxiv·Feb 24, 2023
- EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism
Elham Hasheminasabgorji, Huey‐Miin Chen, … Marco Gallo·Acta Neuropathologica CommunicationsPeer-reviewed·Nov 7, 2025
- H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2
S. U. Jain, A. Q. Rashoff, … P. W. Lewis·bioRxiv·Aug 5, 2020
- Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
Jay F. Sarthy, Michael P. Meers, … Steven Henikoff·eLifePeer-reviewed·Sep 9, 2020